Document is current
Any future updates will be listed below
-
Authors
Seeley, Randy J. https://orcid.org/0000-0002-3721-5625
MacDougald, Ormond A.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DK089503)
U.S. Department of Health & Human Services | National Institutes of Health (DK117821)
U.S. Department of Health & Human Services | National Institutes of Health (DK121759)
U.S. Department of Health & Human Services | National Institutes of Health (DK125513)
U.S. Department of Health & Human Services | National Institutes of Health (AG069795)
- License Information
-
More Information
Article History
First Online: 25 March 2021
Competing interests
: R.J.S. has received research support from Novo Nordisk, AstraZeneca, Pfizer and Kintai; has received consulting fees from Novo Nordisk, Kintai and Scohia; and has equity positions in Zafgen, Calibrate Health and Rewind. O.A.M. has received research support from Novo Nordisk, Regeneron, AstraZeneca and Agilent.
